Publications
Detailed Information
Absence of STAT1 disturbs the anticancer effect induced by STAT3 inhibition in head and neck carcinoma cell lines
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shim, Seon-Hui | - |
dc.contributor.author | Sung, Myung-Whun | - |
dc.contributor.author | Park, Seok-Woo | - |
dc.contributor.author | Heo, Dae Seog | - |
dc.date.accessioned | 2012-07-05T01:15:45Z | - |
dc.date.available | 2012-07-05T01:15:45Z | - |
dc.date.issued | 2009-06 | - |
dc.identifier.citation | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; Vol.23 6; 805-810 | ko_KR |
dc.identifier.issn | 1107-3756 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78535 | - |
dc.description.abstract | The family of signal transducers and activators of transcription (STAT) are transcription factors. Among them, STAT I is associated with an apoptosis pathway, while STAT3 is associated with tumorigenicity in various cancer cells. In order to investigate the primary roles of STAT I and STAT3 in head and neck squamous cell carcinoma (HNSCC), we blocked STAT3 with two JAK inhibitors: AG490 (JAK2-STAT3 pathway inhibitor) and JAK total inhibitor. When we inhibited STAT3 with AG490, significant cell death was observed. However, in the case of JAK kinase total inhibitor, no cell growth retardation was observed. We focused on the role of STAT1 in this phenomenon. Suppression of STAT1 by si-RNA resulted in increased cell survival. Furthermore, the growth inhibitory effect of AG490 was reduced by treatment with si-RNA of STAT1. These results reveal that STAT1 is required to promote the tumor killing effect of STAT3 inhibition in HNSCC. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | SPANDIDOS PUBL LTD | ko_KR |
dc.subject | JAK inhibition | ko_KR |
dc.subject | Stat1 | ko_KR |
dc.subject | head and neck squamous cell carcinoma | ko_KR |
dc.subject | Stat3 inhibition | ko_KR |
dc.subject | Stat3 | ko_KR |
dc.title | Absence of STAT1 disturbs the anticancer effect induced by STAT3 inhibition in head and neck carcinoma cell lines | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 심선휘 | - |
dc.contributor.AlternativeAuthor | 성명훈 | - |
dc.contributor.AlternativeAuthor | 박석우 | - |
dc.contributor.AlternativeAuthor | 허대석 | - |
dc.identifier.doi | 10.3892/ijmm_00000196 | - |
dc.citation.journaltitle | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | - |
dc.description.citedreference | Lui VWY, 2007, MOL PHARMACOL, V71, P1435, DOI 10.1124/mol.106.032284 | - |
dc.description.citedreference | Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275 | - |
dc.description.citedreference | Mora LB, 2002, CANCER RES, V62, P6659 | - |
dc.description.citedreference | Janjua S, 2002, CELL DEATH DIFFER, V9, P1140, DOI 10.1038/sj.cdd.4401082 | - |
dc.description.citedreference | Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909 | - |
dc.description.citedreference | Huang SY, 2002, ONCOGENE, V21, P2504, DOI 10.1038/sj/onc/1205341 | - |
dc.description.citedreference | Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543 | - |
dc.description.citedreference | Sinibaldi D, 2000, ONCOGENE, V19, P5419 | - |
dc.description.citedreference | Song JI, 2000, ONCOGENE, V19, P2489 | - |
dc.description.citedreference | Decker T, 2000, ONCOGENE, V19, P2628 | - |
dc.description.citedreference | Ramana CV, 2000, ONCOGENE, V19, P2619 | - |
dc.description.citedreference | Ouchi T, 2000, P NATL ACAD SCI USA, V97, P5208 | - |
dc.description.citedreference | Grandis JR, 2000, LARYNGOSCOPE, V110, P868 | - |
dc.description.citedreference | Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227 | - |
dc.description.citedreference | Schaefer LK, 1999, BIOCHEM BIOPH RES CO, V266, P481 | - |
dc.description.citedreference | Turkson J, 1999, MOL CELL BIOL, V19, P7519 | - |
dc.description.citedreference | Lim CP, 1999, J BIOL CHEM, V274, P31055 | - |
dc.description.citedreference | Bromberg JF, 1999, CELL, V98, P295 | - |
dc.description.citedreference | Gollob JA, 1999, J IMMUNOL, V162, P4472 | - |
dc.description.citedreference | Grandis JR, 1998, J CLIN INVEST, V102, P1385 | - |
dc.description.citedreference | Bromberg JF, 1998, MOL CELL BIOL, V18, P2553 | - |
dc.description.citedreference | Kumar A, 1997, SCIENCE, V278, P1630 | - |
dc.description.citedreference | Chung JK, 1997, MOL CELL BIOL, V17, P6508 | - |
dc.description.citedreference | Zhu XJ, 1997, MOL CELL BIOL, V17, P6618 | - |
dc.description.citedreference | Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062 | - |
dc.description.citedreference | DAVID M, 1995, SCIENCE, V269, P1721 | - |
dc.description.citedreference | WEN ZL, 1995, CELL, V82, P241 | - |
dc.description.tc | 4 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.